These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 34866586)

  • 1. The DESolve novolimus bioresorbable Scaffold: from bench to bedside.
    Mattesini A; Bartolini S; Sorini Dini C; Valente S; Parodi G; Stolcova M; Meucci F; Di Mario C
    J Thorac Dis; 2017 Aug; 9(Suppl 9):S950-S958. PubMed ID: 28894601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully bioresorbable drug-eluting coronary scaffolds: A review.
    Charpentier E; Barna A; Guillevin L; Juliard JM
    Arch Cardiovasc Dis; 2015; 108(6-7):385-97. PubMed ID: 26113479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
    İbişoğlu E; Çakal S; Çakal B; Güneş HM; Boyraz B; Boztosun B
    Anatol J Cardiol; 2021 Dec; 25(12):912-919. PubMed ID: 34866586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds.
    Gunes HM; Gokdeniz T; Kizilirmak Yilmaz F; Demir GG; Guler E; Babur Guler G; Karaca O; Cakal B; Omaygenç MO; İbişoğlu E; Boztosun B
    J Interv Cardiol; 2017 Jun; 30(3):189-194. PubMed ID: 28440067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DESolve
    Demola P; Meucci F; Stolcova M; Mario CD; Mattesini A
    Future Cardiol; 2021 Sep; 17(6):945-951. PubMed ID: 33507091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of the novolimus-eluting bioresorbable vascular scaffold in real world clinical practice.
    Cakal B; Cakal S; Karaca O; Omaygenc MO; Yilmaz FK; Gunes HM; Ozcan OU; Ibisoglu E; Boztosun B
    Minerva Cardiol Angiol; 2021 Jun; 69(3):261-268. PubMed ID: 32326676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry.
    Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions.
    Verheye S; Costa RA; Schofer J; Ormiston JA; Maeng M; Dudek D; Skurk C; Botelho RV; Costa JR; Chamié D; Abizaid AS; Boersma E; Abizaid AA
    EuroIntervention; 2019 Oct; 15(8):685-687. PubMed ID: 30530403
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicenter post-marketing evaluation of the Elixir DESolve
    Nef H; Wiebe J; Boeder N; Dörr O; Bauer T; Hauptmann KE; Latib A; Colombo A; Fischer D; Rudolph T; Foin N; Richardt G; Hamm C
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1021-1027. PubMed ID: 29508518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
    Ali ZA; Gao R; Kimura T; Onuma Y; Kereiakes DJ; Ellis SG; Chevalier B; Vu MT; Zhang Z; Simonton CA; Serruys PW; Stone GW
    Circulation; 2018 Jan; 137(5):464-479. PubMed ID: 29089314
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.